[Federal Register Volume 88, Number 113 (Tuesday, June 13, 2023)]
[Proposed Rules]
[Pages 38407-38408]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12589]
========================================================================
Proposed Rules
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.
========================================================================
Federal Register / Vol. 88 , No. 113 / Tuesday, June 13, 2023 /
Proposed Rules
[[Page 38407]]
NUCLEAR REGULATORY COMMISSION
10 CFR Part 35
[NRC-2023-0086]
Draft Regulatory Guide: Release of Patients Administered
Radioactive Material
AGENCY: Nuclear Regulatory Commission.
ACTION: Draft guide; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On April 21, 2023, the U.S. Nuclear Regulatory Commission
(NRC) solicited comments on draft regulatory guide (DG), DG-8061,
``Release of Patients Administered Radioactive Material.'' The public
comment period was originally scheduled to close on June 20, 2023. The
NRC has decided to extend the public comment period to allow more time
for members of the public to develop and submit their comments.
DATES: The due date for comments requested in the document published on
April 21, 2023 (88 FR 24495) is extended. Comments should be submitted
no later than August 20, 2023. Comments received after this date will
be considered, if it is practical to do so, but the Commission is able
to ensure consideration only for comments received on or before this
date.
ADDRESSES: You may submit comments by any of the following methods;
however, the NRC encourages electronic comment submission through the
Federal rulemaking website:
Federal rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0086. Address
questions about Docket IDs in Regulations.gov to Stacy Schumann;
telephone: 301-415-0624; email: [email protected]. For technical
questions, contact the individuals listed in the For Further
Information Contact section of this document.
Mail comments to: Office of Administration, Mail Stop:
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Katherine Tapp, Office of Nuclear
Material Safety and Safeguards, telephone: 301-415-0236, email:
[email protected], or Brian Allen, Office of Nuclear Regulatory
Research, telephone: 301-415-8402, email: [email protected], or
Rigel Flora, Office of Nuclear Regulatory Research, telephone: 301-415-
3890, email: [email protected], or Harriet Karagiannis, Office of
Nuclear Regulatory Research, telephone: 301-415-2493, email:
[email protected]. All are staff of the U.S. Nuclear
Regulatory Commission, Washington, DC 20555-0001.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
I. Obtaining Information
Please refer to Docket ID NRC-2023-0086 when contacting the NRC
about the availability of information for this action. You may obtain
publicly available information related to this action by any of the
following methods:
Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0086.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or
by email to [email protected].
NRC's PDR: You may examine and purchase copies of public
documents, by appointment, at the NRC's PDR, Room P1 B35, One White
Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make
an appointment to visit the PDR, please send an email to
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8
a.m. and 4 p.m. eastern time (ET), Monday through Friday, except
Federal holidays.
B. Submitting Comments
The NRC encourages electronic comment submission through the
Federal rulemaking website (https://www.regulations.gov). Please
include Docket ID NRC-2023-0086 in your comment submission.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC will post all comment submissions at
https://www.regulations.gov as well as enter the comment submissions
into ADAMS. The NRC does not routinely edit comment submissions to
remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Discussion
On April 21, 2023, the NRC published a document in the Federal
Register (88 FR 24495) requesting comments on DG-8061, ``Release of
Patients Administered Radioactive Material.'' This DG is proposed
Revision 2 to Regulatory Guide (RG) 8.39 of the same title. This
proposed revision provides licensees with methods that are acceptable
to the NRC for the release of patients after a medical procedure
involving the administration of unsealed byproduct material, such as
radiopharmaceuticals, or implants that contain radioactive material.
The comment period was originally scheduled to close on June 20, 2023.
Upon the request of the medical community, the NRC has decided to
extend the public comment period on this document until August 20,
2023, to allow more time for members of the public to submit their
comments.
[[Page 38408]]
III. Submitting Suggestions for Improvement of Regulatory Guides
A member of the public may, at any time, submit suggestions to the
NRC for improvement of existing RGs or for the development of new RGs.
Suggestions can be submitted on the NRC's public website at https://www.nrc.gov/reading-rm/doc-collections/reg-guides/contactus.html.
Suggestions will be considered in future updates and enhancements to
the ``Regulatory Guide'' series.
Dated: June 7, 2023.
For the Nuclear Regulatory Commission.
Meraj Rahimi,
Chief, Regulatory Guide and Programs Management Branch, Division of
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2023-12589 Filed 6-12-23; 8:45 am]
BILLING CODE 7590-01-P